{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:23Z","timestamp":1788415943785,"version":"build-2803163510"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tenofovir disoproxil fumarate (TDF) is a key antiretroviral agent for preventing mother-to-child transmission of human immunodeficiency virus (HIV) and treating chronic hepatitis B (HBV) during pregnancy. However, concerns persist regarding its potential effects on bone metabolism during foetal development and postpartum recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This scoping review synthesised evidence on the impact of\n                      <jats:italic>in utero<\/jats:italic>\n                      and lactational TDF exposure on bone health in offspring and mothers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of PubMed, Scopus, Web of Science and the China National Knowledge Infrastructure identified randomised controlled trials, cohort studies, and observational studies assessing bone mineral density, bone mineral content, growth, or bone turnover markers in relation to perinatal TDF exposure. Thirty-one studies met the inclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most studies reported no clinically significant long-term effects of TDF on paediatric bone mineralisation, growth, or metabolism from infancy to mid-childhood. A transient reduction in neonatal bone mineral content was noted in a few studies, but its clinical relevance appeared limited. In contrast, TDF use in mothers was consistently associated with accentuated bone loss during pregnancy and lactation, particularly at the hip, with incomplete recovery postpartum, indicating potential long-term skeletal risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In utero<\/jats:italic>\n                      and lactational exposure to TDF had minimal impact on paediatric bone development but was consistently linked to maternal bone loss and incomplete skeletal recovery. While the benefits of TDF in preventing vertical transmission of HIV and HBV outweigh these risks, the findings highlight the importance of ongoing monitoring of maternal bone health.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1798685","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:05Z","timestamp":1788412445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Xia","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia","place":["Cheras, Malaysia"]},{"name":"Department of Gynaecology and Obstetrics, Inner Mongolia Baogang Hospital","place":["Baotou, China"]},{"name":"Department of Obstetrics & Gynaecology, Tianjin Medical University General Hospital","place":["Heping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia","place":["Cheras, Malaysia"]},{"name":"Chongqing Chemical Industry Vocational College","place":["Changshou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Inner Mongolia Baogang Hospital","place":["Baotou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Lun","family":"Pang","sequence":"additional","affiliation":[{"name":"Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar","place":["Sunway, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong Khee","family":"Cheong","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Department of Internal Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia","place":["Cheras, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norliza","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia","place":["Cheras, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Yong","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia","place":["Cheras, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101462","article-title":"A review of Tenofovir Disoproxil Fumarate associated nephrotoxicity among People Living with HIV: Burden, risk factors and solutions","volume":"25","author":"Asirvatham","year":"2024","journal-title":"Clin Epidemiol Global Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/v14020434","article-title":"Current trend in antiviral therapy for chronic hepatitis B","volume":"14","author":"Chien","year":"2022","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000525518","article-title":"Hepatitis B virus treatment and hepatocellular carcinoma: Controversies and approaches to consensus","volume":"11","author":"Kim","year":"2022","journal-title":"Liver Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17040","article-title":"Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection","volume":"56","author":"Kayes","year":"2022","journal-title":"Alimentary Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2216","article-title":"Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis of randomised control trials","volume":"31","author":"Zeleke","year":"2021","journal-title":"Rev Med Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202264010","article-title":"Tenofovir-induced renal and bone toxicity: report of two cases and literature review","volume":"64","author":"Fioroti","year":"2022","journal-title":"Rev do Instituto Med Trop S\u00e3o Paulo"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003656","article-title":"Bone mineral content, growth, and renal health of infants with perinatal exposure to maternal dolutegravir versus efavirenz and tenofovir disoproxil fumarate versus tenofovir alafenamide: The randomized IMPAACT 2010 (VESTED) trial [Article","volume":"99","author":"Mbengeranwa","year":"2025","journal-title":"J Acquired Immune Deficiency Syndromes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1076739","article-title":"Changes in bone quality after switching from a TDF to a TAF based ART: A pilot randomized study","volume":"14","author":"Soldado-Folgado","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01387-2","article-title":"Maternal and fetal vitamin D and their roles in mineral homeostasis and fetal bone development","volume":"44","author":"Ryan","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2024.05.003","article-title":"Bone metabolism, bone mass, and bone structure during pregnancy and lactation: Normal physiology and pregnancy and lactation-associated osteoporosis","volume":"53","author":"Cohen","year":"2024","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(23)00261-8","article-title":"Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial","volume":"10","author":"Landovitz","year":"2023","journal-title":"Lancet HIV"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae288","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for preventing vertical transmission in chronic hepatitis B mothers: A systematic review and meta-analysis","volume":"79","author":"Pan","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14497","article-title":"Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B","volume":"47","author":"Wong","year":"2018","journal-title":"Alimentary Pharmacol Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jpids\/piae054","article-title":"Phosphaturia in HIV-exposed uninfected neonates associated with maternal use of tenofovir disoproxil fumarate in late pregnancy [Article","volume":"13","author":"Purswani","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2391496","article-title":"Comparative evaluation of adverse drug reactions for tenofovir alafenamide and tenofovir disoproxil fumarate using the FAERS Database: a disproportionality analysis","volume":"24","author":"Zhu","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4866","article-title":"Biochemical markers of calcium and bone metabolism during and after lactation in Ugandan women with HIV on universal maternal antiretroviral therapy","volume":"38","author":"Nabwire","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/gutjnl-2020-322719","article-title":"Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China [Article","volume":"71","author":"Pan","year":"2022","journal-title":"Gut"},{"key":"B18","article-title":"Effects of antiviral therapy with tenofovir disoproxil fumarate during pregnancy on bone metabolism of pregnant women and bone mineral density of newborns","volume":"13","author":"Ma","year":"2021","journal-title":"Chin J Liver Diseases(Electronic Version)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26379","article-title":"In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa","volume":"27","author":"Reddy","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.001","article-title":"Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B","volume":"80","author":"Yip","year":"2024","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Method"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7326\/m18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Internal Med"},{"key":"B23","unstructured":"2024"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw268","article-title":"Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi","volume":"71","author":"Floridia","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001217","article-title":"Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial","volume":"9","author":"Gibb","year":"2012","journal-title":"PloS Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000747","article-title":"Meconium tenofovir concentrations and growth and bone outcomes in prenatally tenofovir exposed HIV-uninfected children","volume":"34","author":"Himes","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw159","article-title":"In utero tenofovir exposure is not associated with fetal long bone growth [Article","volume":"62","author":"Jao","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002152","article-title":"Tenofovir disoproxil fumarate use during pregnancy and infant bone health: The Tenofovir in Pregnancy Pilot Study [Article","volume":"37","author":"Kourtis","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/jbmr\/zjag024","article-title":"Longitudinal comparison of bone, growth and biochemical markers in breastfed HIV-exposed uninfected and HIV-unexposed Ugandan children","volume":"41","author":"Nabwire","year":"2026","journal-title":"J Bone Miner Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000001386","article-title":"Bone age and mineral density assessments using plain roentgenograms in tenofovir-exposed infants in Malawi and Brazil enrolled in HIV Prevention Trials Network 057","volume":"36","author":"Osorio","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy982","article-title":"Maternal and infant bone mineral density 1 year after delivery in a randomized, controlled trial of maternal tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus [Article","volume":"69","author":"Salvadori","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.03.023","article-title":"Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy [Article","volume":"105","author":"Shang","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy [article","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000003218","article-title":"Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial","volume":"93","author":"Vhembo","year":"2023","journal-title":"J Acquired Immune Deficiency Syndromes"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1909","article-title":"In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers [article","volume":"16","author":"Vigan\u00f2","year":"2011","journal-title":"Antiviral Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.16506\/j.1009-6639.2020.01.007","article-title":"Tenofovir treatment during late pregnancy blocks the vertical transmission of HBV with no obvious impact on bone mineral density of infants via breast-feeding","volume":"21","author":"Wang","year":"2020","journal-title":"Chin Prev Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.01.021","article-title":"Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate [article","volume":"72","author":"Wen","year":"2020","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/qai.0000000000002515","article-title":"Growth and neurodevelopment outcomes in HIV-, tenofovir-, and efavirenz-exposed breastfed infants in the PMTCT Option B+ program in Malawi","volume":"86","author":"Kapito-Tembo","year":"2021","journal-title":"J Acquired Immune Deficiency Syndromes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246272","article-title":"Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial","volume":"16","author":"Stranix-Chibanda","year":"2021","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250828","article-title":"Influence of maternal use of tenofovir disoproxil fumarate or zidovudine in Vietnamese pregnant women with HIV on infant growth, renal function, and bone health [Article","volume":"16","author":"Kinai","year":"2021","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000003563","article-title":"Tenofovir disoproxil fumarate\/emtricitabine prophylaxis has no effect on bone mineral density and bone mineral content in African breastfeeding women receiving pre-exposure prophylaxis for HIV","volume":"98","author":"Kistan","year":"2025","journal-title":"J Acquired Immune Deficiency Syndromes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003478","article-title":"Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) trial [Article","volume":"97","author":"Masheto","year":"2024","journal-title":"J Acquired Immune Deficiency Syndromes (1999)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000004148","article-title":"Bone mineral density changes in breastfeeding women with HIV on antiretroviral therapy in Eastern and Southern Africa","volume":"39","author":"Matovu","year":"2025","journal-title":"Aids"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/08903344221146472","article-title":"Milk calcium and phosphorus in Ugandan women with HIV on tenofovir-based antiretroviral therapy","volume":"39","author":"Nabwire","year":"2023","journal-title":"J Hum Lactation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4121","article-title":"Changes in bone mineral density during and after lactation in Ugandan women with HIV on tenofovir-based antiretroviral therapy","volume":"35","author":"Nabwire","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000003719","article-title":"Impact of tenofovir disoproxil fumarate use during pregnancy on maternal bone mineral density","volume":"41","author":"Wang","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B47","article-title":"Safety of tenofovir disoproxil fumarate in pregnant women with HBV infection: An observation on renal functions and fetal growths","volume":"25","author":"Xiong","year":"2022","journal-title":"J Pract Hepatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ010","article-title":"Recommendations for evaluation and management of bone disease in HIV","volume":"60","author":"Brown","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/coh.0000000000000780","article-title":"Gender and sex considerations in HIV and bone health","volume":"18","author":"Tang","year":"2023","journal-title":"Curr Opin HIV AIDS"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/v17030442","article-title":"Understanding HIV-exposed uninfected children: A narrative review","volume":"17","author":"Salvi","year":"2025","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25426","article-title":"Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: Where are we now and where are we heading? [Review","volume":"23","author":"Joseph-Davey","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3851\/imp3269","article-title":"Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone","volume":"23","author":"Havens","year":"2018","journal-title":"Antiviral Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004029","article-title":"Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception [Article","volume":"39","author":"Heffron","year":"2025","journal-title":"Aids"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00197","article-title":"Effect of antiretroviral therapy on bone and renal health in young adults infected with HIV in early life","volume":"102","author":"Unsal","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"Van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-025-00805-y","article-title":"Antiseizure medications and bone health","volume":"14","author":"Gaete","year":"2025","journal-title":"Neurol Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302010000200008","article-title":"Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review","volume":"54","author":"Carvalho","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(95)70304-7","article-title":"Effect of carbamazepine and valproate on bone mineral density","volume":"127","author":"Sheth","year":"1995","journal-title":"J Pediatr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/80.6.1725S","article-title":"Nutritional rickets: deficiency of vitamin D, calcium, or both","volume":"80","author":"Pettifor","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ph17020146","article-title":"Effects of Tenofovir Disoproxil Fumarate on bone quality beyond bone density-a scoping review of the literature","volume":"17","author":"Hashwin Singh","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001780","article-title":"Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate","volume":"32","author":"G\u00fcerri-Fern\u00e1ndez","year":"2018","journal-title":"Aids"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001396","article-title":"Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir\/emtricitabine or abacavir\/lamivudine","volume":"75","author":"G\u00fcerri-Fern\u00e1ndez","year":"2017","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115509","article-title":"Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study","volume":"138","author":"Macdonald","year":"2020","journal-title":"Bone"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217669","article-title":"Bone quality beyond DXA in people living with HIV: A systematic review of HR-pQCT, TBS, microindentation, and vertebral fractures","volume":"14","author":"Razvan","year":"2025","journal-title":"J Clin Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810705","article-title":"The role of vitamin D and vitamin D binding protein in chronic liver diseases","volume":"23","author":"Pop","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161402","article-title":"Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology [review","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol"},{"key":"B68","first-page":"53","article-title":"Osteoporosis in patients with chronic liver disease: pathogenesis, diagnosis and treatment","volume-title":"Bukovinian Medical Herald","author":"Tkachenko","year":"2023"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4765","article-title":"The impact of human immunodeficiency virus and menopause on bone mineral density: A longitudinal study of urban-dwelling South African women","volume":"38","author":"Madanhire","year":"2023","journal-title":"J Bone Miner Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1798685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:07Z","timestamp":1788412447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1798685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":69,"alternative-id":["10.3389\/fendo.2026.1798685"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1798685","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1798685"}}